Key result
Top 2023 cardiology papers spotlight advances in dyslipidemia and ASCVD management.
Design
Review
Answers are grounded in this paper and cite their sources.
Summarizes the top 10 papers in dyslipidemias and atherosclerotic cardiovascular disease published in 2023.
New insights and treatment options for dyslipidemia and atherosclerotic cardiovascular disease. CV, cardiovascular; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); PCSK9, proprotein convertase subtilisin/kexin type 9; TGRL, triglyceride-rich lipoprotein; VLDL-C, very low-density lipoprotein cholesterol.
No takes yet. Share an insight, caveat, or question.
Tokgözoğlu et al. (2023) studied this question. The top 10 cardiovascular medicine papers of 2023 highlighted new insights and treatment options for dyslipidemia and atherosclerotic cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: